CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
Do Young Kim, Jehyun Nam, Joo-Seop Chung, Byeol Eun Jeon, Ji Hyun Lee, Jae-Cheol Jo, Sang-Woo Kim, Ho-Jin Shin
Cancer Research and Treatment. 2022;54(4):1256-1267.   Published online 2021 December 31    DOI: https://doi.org/10.4143/crt.2021.944

Excel Download

Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
Cancer Research and Treatment. 2022;54(4):1256-1267   Crossref logo
Link1 Link2 Link3

PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma Patients
Value in Health. 2011;14(7):A434-A435   Crossref logo
Link1 Link2

Prophylactic Pegfilgrastim Significantly Reduces Febrile Neutropenia During Moderately Myelosuppressive Chemotherapy
Supportive Cancer Therapy. 2004;1(4):207-209   Crossref logo
Link1 Link2

Impact of Age Group on Febrile Neutropenia Risk Assessment and Management in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Regimens
Clinical Lymphoma Myeloma and Leukemia. 2012;12(5):297-305   Crossref logo
Link1 Link2

COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim
. 2022;   Crossref logo
Link1 Link2

Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
Journal of Korean Medical Science. 2014;29(11):1493   Crossref logo
Link1 Link2 Link3

Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP
International Journal of Clinical Oncology. 2013;19(1):178-185   Crossref logo
Link1 Link2 Link3

Predictive factors of febrile neutropenia after pegfilgrastim as primary prophylaxis in patients treated with neoadjuvant chemotherapy of docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer: Impact of febrile neutropenia on changes in neutrophil counts and relative dose intensity
. 2022;   Crossref logo
Link1 Link2

Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis
Cancer Research and Treatment. 2014;47(3):448-457   Crossref logo
Link1 Link2 Link3

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: A systematic review
. 2022;   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.